Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan
· Delayed Price · Currency is TWD 31.50
+0.10 (0.32%)
Mar 10, 2026, 10:02 AM CST
Taiyen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,280 | 6,490 | 6,840 | 6,490 | 6,640 | 6,540 | Upgrade
|
| Market Cap Growth | -3.38% | -5.12% | 5.39% | -2.26% | 1.53% | 0.61% | Upgrade
|
| Enterprise Value | 4,740 | 4,991 | 5,405 | 4,866 | 5,217 | 4,966 | Upgrade
|
| Last Close Price | 31.40 | 31.19 | 31.72 | 28.80 | 28.18 | 26.66 | Upgrade
|
| PE Ratio | 18.91 | 17.47 | 22.77 | 15.21 | 16.89 | 17.91 | Upgrade
|
| Forward PE | - | 15.52 | 15.52 | 15.52 | 15.52 | 15.52 | Upgrade
|
| PS Ratio | 1.92 | 2.00 | 2.01 | 1.80 | 1.62 | 2.09 | Upgrade
|
| PB Ratio | 0.94 | 0.97 | 1.04 | 0.97 | 1.02 | 1.03 | Upgrade
|
| P/TBV Ratio | 0.95 | 0.98 | 1.06 | 1.00 | 1.05 | 1.05 | Upgrade
|
| P/FCF Ratio | 22.60 | 18.41 | 60.59 | 19.40 | 31.43 | 87.68 | Upgrade
|
| P/OCF Ratio | 11.48 | 9.83 | 15.05 | 11.18 | 11.07 | 19.27 | Upgrade
|
| EV/Sales Ratio | 1.45 | 1.54 | 1.59 | 1.35 | 1.27 | 1.59 | Upgrade
|
| EV/EBITDA Ratio | 7.61 | 9.02 | 10.62 | 7.74 | 7.37 | 7.76 | Upgrade
|
| EV/EBIT Ratio | 12.38 | 14.40 | 16.81 | 10.93 | 9.86 | 10.72 | Upgrade
|
| EV/FCF Ratio | 17.06 | 14.16 | 47.88 | 14.54 | 24.69 | 66.59 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.03 | 0.03 | 0.02 | 0.06 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.36 | 0.42 | 0.21 | 0.55 | 0.32 | Upgrade
|
| Debt / FCF Ratio | 0.48 | 0.58 | 1.95 | 0.41 | 1.86 | 2.78 | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.25 | -0.25 | -0.26 | -0.26 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.51 | -3.06 | -3.18 | -2.78 | -2.38 | -2.62 | Upgrade
|
| Net Debt / FCF Ratio | -5.54 | -4.80 | -14.34 | -5.22 | -7.99 | -22.54 | Upgrade
|
| Asset Turnover | 0.40 | 0.39 | 0.41 | 0.43 | 0.50 | 0.41 | Upgrade
|
| Inventory Turnover | 5.05 | 4.67 | 5.36 | 5.83 | 7.66 | 5.72 | Upgrade
|
| Quick Ratio | 2.12 | 2.06 | 2.29 | 2.77 | 2.18 | 3.55 | Upgrade
|
| Current Ratio | 2.63 | 2.51 | 2.75 | 3.34 | 2.60 | 4.17 | Upgrade
|
| Return on Equity (ROE) | 4.95% | 4.80% | 3.29% | 6.49% | 6.40% | 5.99% | Upgrade
|
| Return on Assets (ROA) | 2.91% | 2.59% | 2.43% | 3.33% | 4.07% | 3.76% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.99% | 5.13% | 4.31% | 7.36% | 9.00% | 8.23% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.30% | 4.80% | 4.50% | 6.10% | 7.40% | 6.50% | Upgrade
|
| Earnings Yield | 5.31% | 5.73% | 4.39% | 6.58% | 5.92% | 5.58% | Upgrade
|
| FCF Yield | 4.42% | 5.43% | 1.65% | 5.16% | 3.18% | 1.14% | Upgrade
|
| Dividend Yield | 4.11% | 4.17% | 3.78% | 5.21% | 5.32% | 5.06% | Upgrade
|
| Payout Ratio | 77.98% | 64.60% | 99.87% | 70.31% | 68.66% | 82.17% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.06% | 0.08% | -0.05% | - | -0.02% | Upgrade
|
| Total Shareholder Return | 4.03% | 4.11% | 3.87% | 5.16% | 5.32% | 5.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.